George Elston | Chief Financial Officer |
Nancy Lurker | President and Chief Executive Officer |
Jay Duker | Chief Operating Officer |
Scott Jones | Chief Commercial Officer |
Stacy Ku | Cowen |
Eddie Hickman | Guggenheim Partners |
Jennifer Kim | Cantor |
Yale Jen | Laidlaw |
Yi Chen | H.C. Wainwright |
Good morning. My name is Michelle, and I’ll be your conference operator today. At this time, I would like to welcome everyone to the EyePoint Pharmaceuticals Second Quarter 2022 Financial Results and Recent Corporate Developments Conference Call. There’ll be a question-and-answer session to follow at the completion of the prepared remarks. Please be advised that this call is being recorded at the company’s request.